ACTUATE THERAPEUTICS, INC.

ACTU

ACTUATE THERAPEUTICS, INC.

ACTU

Insider Sentiment (TTM):

Last Purchase:2025-06-27Last Sale:2026-01-05Shares Purchased (TTM):0Shares Sold (TTM):280,000

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:13,856,355Shares Outstanding:23,537,134Institutional Ownership Pct.:58.87%

Earnings Market Reaction:

Filing Date:2026-05-14Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Pharmaceutical Preparations

LLY JNJ ABBV MRK ABT PFE

ACTUATE THERAPEUTICS, INC. (ACTU) — SEC Financial Statements & Analysis

ACTUATE THERAPEUTICS, INC. (ACTU) files its annual 10-K and quarterly 10-Q reports directly with the SEC. The financial data below is sourced as-filed from EDGAR — balance sheet, income statement, and cash flow as reported, without normalization or third-party adjustments.

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Assets
Assets Current
Cash Equivalents At Carrying Value	8	13	17	6	4	9	14	0
Prepaid Expense And Other Assets Current	0	0	1	0	0	1	1	0
Assets Current	9	14	17	7	4	9	14	1
Deferred Costs	-	-	-	-	-	-	-	1
Other Assets Noncurrent	0	0	0	0	0	0	-	-
Assets	9	14	18	7	4	9	14	2
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	1	2	1	3	3	2	2	6
Other Accrued Liabilities Current	3	4	4	5	5	6	6	7
Convertible Notes Payable Current	-	-	-	-	-	-	-	7
Accrued Salaries Current	1	1	1	1	1	1	0	0
Interest Payable Current	0	0	0	0	0	0	0	0
Liabilities Current	5	6	6	9	9	9	8	20
Liabilities Noncurrent
Other Accrued Liabilities Noncurrent	-	-	-	-	-	0	0	1
Interest Payable Current And Noncurrent	-	-	-	-	0	0	0	0
Accounts Payable Other Current And Noncurrent	-	-	-	-	0	0	0	0
Liabilities Noncurrent	0	0	0	0	0	0	0	2
Liabilities	5	6	7	10	10	9	9	22
Stockholders Equity
Temporary Equity Carrying Amount Attributable To P…	-	-	-	-	-	0	0	94
Preferred Stock Value	0	0	0	0	0	0	0	-
Common Stock Value	0	0	0	0	0	0	0	0
Additional Paid In Capital	164	163	161	142	134	132	131	6
Retained Earnings Accumulated Deficit	-160	-155	-150	-145	-139	-132	-126	-120
Stockholders Equity	4	8	11	-3	-5	0	5	-114
Liabilities And Stockholders Equity	9	14	18	7	4	9	14	2
Preferred Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	-
Preferred Stock Shares Authorized	10	10	10	10	10	10	10	-
Temporary Equity Par Or Stated Value Per Share	-	-	-	-	-	0	0	0
Preferred Stock Shares Issued	0	0	0	0	0	0	0	-
Temporary Equity Shares Authorized	-	-	-	-	-	0	0	33
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	-
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0
Temporary Equity Shares Issued	-	-	-	-	-	0	0	25
Temporary Equity Shares Outstanding	-	-	-	-	-	0	0	25
Common Stock Shares Authorized	200	200	200	200	200	200	200	267
Common Stock Shares Issued	24	23	23	20	20	20	20	24
Temporary Equity Liquidation Preference	-	-	-	-	-	0	0	125
Shares Outstanding	24	23	23	20	20	20	20	24

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-35.17%	-47.59%	-	-	-	-	-	-	-	-	-	-
2025	-8.20%	-32.48%	-25.61%	0.24%	-15.09%	-18.98%	25.00%	2.55%	-19.90%	1.76%	15.42%	-11.01%
2024	-	-	-	11.35%	33.13%	32.21%	4.56%	-2.69%	5.49%	-7.52%	41.34%	59.73%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 50+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Liquidity Ratios
Current Ratio	1.80	2.39	2.74	0.73	0.46	1.05	1.68	0.03
Quick Ratio	1.72	2.31	2.66	0.71	0.42	0.98	1.59	0.02
Working Capital	3.80M	7.94M	11.07M	-2.51M	-4.91M	405.40K	5.77M	-19.52M
Leverage & Debt
Debt to Equity	1.35	0.77	0.62	-3.63	-1.88	88.44	1.66	-0.19
Interest Coverage TTM	-1,078.36	-1,110.88	-1,268.32	-1,348.98	-1,325.75	-	-	-
Debt Ratio	0.58	0.44	0.38	1.38	2.13	0.99	0.62	12.60
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	-	-	-
Per Share Metrics
Diluted EPS TTM	-0.92	-1.06	-1.52	-1.68	-1.72	-	-	-
Free Cash Flow Per Share TTM	-0.83	-0.91	-0.95	-1.16	-1.36	-	-	-
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	-	-	-
Growth Metrics
Net Income Growth (1Y)	-35.91%	-	-	-	-	-	-	-
EPS Growth (1Y)	-46.91%	-	-	-	-	-	-	-
Valuation Metrics
P/E TTM	-2.99	-5.79	-4.42	-3.64	-3.93	-	-	-
P/B	17.04	16.24	13.09	-45.23	-25.94	639.69	14.98	-
Market Cap	64.49M	128.65M	143.13M	120.04M	132.00M	66.65M	80.26M	-
Enterprise Value	56.36M	115.49M	126.21M	113.55M	128.11M	58.01M	66.73M	-
Calculated Values
Free Cash Flow TTM	-19.60M	-19.21M	-20.24M	-22.71M	-26.46M	-	-	-
Net Debt	-8.13M	-13.16M	-16.92M	-6.49M	-3.89M	-8.64M	-13.52M	6.55M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-01-05Sale

Owner: Thomson, Todd S, Kairos V…

Title: -

Shares: 280,000

Price/Share: $5.80

Value: $1,624,000.00

Shares Owned: 904,795

Relationship: Director,TenPercentOwner

Ownership: Indirect

2025-06-27Purchase

Owner: Bios, Fund Ii, Lp, Bios F…

Title: -

Shares: 71,428

Price/Share: $7.00

Value: $499,996.00

Shares Owned: 196,428

Relationship: Director,TenPercentOwner

Ownership: Indirect

2025-06-27Purchase

Owner: Bios, Equity Cof, Lp, Bio…

Title: -

Shares: 71,428

Price/Share: $7.00

Value: $499,996.00

Shares Owned: 196,428

Relationship: Director,TenPercentOwner

Ownership: Indirect

2025-06-27Purchase

Owner: Bios, Actuate Co-Invest I…

Title: -

Shares: 71,428

Price/Share: $7.00

Value: $499,996.00

Shares Owned: 196,428

Relationship: Director,TenPercentOwner

Ownership: Indirect

2024-08-14Sale

Owner: Bios, Clinical Opportunit…

Title: -

Shares: 24,999

Price/Share: $8.00

Value: $199,992.00

Shares Owned: 131,248

Relationship: Director,TenPercentOwner

Ownership: Indirect

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-01-05	Thomson, Todd S, Kairos V…	Director,TenPercentOwner	-	Indirect	Sale	280,000	5.80	$1,624,000.00	904,795	4
2025-06-27	Bios, Fund Ii, Lp, Bios F…	Director,TenPercentOwner	-	Indirect	Purchase	71,428	7.00	$499,996.00	196,428	4
2025-06-27	Bios, Equity Cof, Lp, Bio…	Director,TenPercentOwner	-	Indirect	Purchase	71,428	7.00	$499,996.00	196,428	4
2025-06-27	Bios, Actuate Co-Invest I…	Director,TenPercentOwner	-	Indirect	Purchase	71,428	7.00	$499,996.00	196,428	4
2024-08-14	Bios, Clinical Opportunit…	Director,TenPercentOwner	-	Indirect	Sale	24,999	8.00	$199,992.00	131,248	4/A
2024-08-14	Bios, Capital Management,…	Director,TenPercentOwner	-	Indirect	Sale	24,999	8.00	$199,992.00	131,248	4/A
2024-08-14	Bios, Fund Ii Qp, Lp, Bio…	Director,TenPercentOwner	-	Indirect	Sale	24,999	9.00	$224,991.00	131,248	4
2024-08-14	Bios, Fund Ii Qp, Lp, Bio…	Director,TenPercentOwner	-	Indirect	Purchase	500,000	8.00	$4,000,000.00	1,259,427	4
2024-08-14	Bios, Equity Partners Iii…	Director,TenPercentOwner	-	Indirect	Sale	24,999	9.00	$224,991.00	131,248	4
2024-08-14	Bp, Directors, Lp, Bios C…	Director,TenPercentOwner	-	Indirect	Sale	24,999	9.00	$224,991.00	131,248	4
2024-08-14	Bp, Directors, Lp, Bios C…	Director,TenPercentOwner	-	Indirect	Purchase	500,000	8.00	$4,000,000.00	1,259,427	4
2024-08-14	Kairos-Actuate, Spv, L.P.…	Director,Other	-	Indirect	Sale	18,750	8.00	$150,000.00	1,184,795	4
2024-08-14	Bios, Fund Ii, Lp, Cavu A…	Director,TenPercentOwner	-	Indirect	Sale	24,999	8.00	$199,992.00	131,248	4/A
2024-08-14	Bios, Equity Partners Iii…	Director,TenPercentOwner	-	Indirect	Purchase	500,000	8.00	$4,000,000.00	1,259,427	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

58.87%

Inst. Shares: 13,856,355

Shares Outstanding: 23,537,134

2025-12-31

62.32%

Inst. Shares: 13,101,440

Shares Outstanding: 21,021,817

2025-09-30

53.36%

Inst. Shares: 11,415,758

Shares Outstanding: 21,394,965

2025-06-30

56.81%

Inst. Shares: 11,161,522

Shares Outstanding: 19,646,475

2025-03-31

53.35%

Inst. Shares: 10,401,592

Shares Outstanding: 19,497,731

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	13,856,355	23,537,134	58.87%
2025-12-31	13,101,440	21,021,817	62.32%
2025-09-30	11,415,758	21,394,965	53.36%
2025-06-30	11,161,522	19,646,475	56.81%
2025-03-31	10,401,592	19,497,731	53.35%
2024-12-31	10,116,136	8,372,741	120.82%
2024-09-30	382,167	10,772,640	3.55%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

ACTUATE THERAPEUTICS, INC. (ACTU) — SEC Financial Statements & Analysis

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.